Physician profile
Christopher R Good
NPI 1568593390
$1,678,196.07
in general payments reported to CMS, 2019-2025
15 companies · $151K in 2025
The $151K reported for 2025 was more than what 95% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244K · 2020: $123K · 2021: $260K · 2022: $210K · 2023: $365K · 2024: $324K · 2025: $151K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $681K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $71K · Consulting Fee: $66K · Travel and Lodging: $18K · Food and Beverage: $3,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $681,186.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $71,450.00 |
| Consulting Fee | $65,950.00 |
| Travel and Lodging | $18,274.94 |
| Food and Beverage | $3,267.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,123,303.43 | 2021-2025 | Mazor X System, Stealthstation S8 Platform, Unid_pass |
| Medtronic USA, INC. | $325,954.16 | 2019-2020 | |
| Stryker Corporation | $161,918.61 | 2019-2025 | Cascadia Interbody System, Everest Spinal System, Ozark Cervical Plate System |
| Augmedics INC. | $39,810.74 | 2020-2025 | Xvision |
| Vb Spine LLC | $26,239.22 | 2025 | Cascadia Interbody System, Vulcan Spinal System, Capri Corpectomy Cage System |
| Aesculap Implant Systems, LLC | $266.94 | 2020-2023 | Activl |
| Centinel Spine, LLC | $240.29 | 2020-2022 | |
| Integrity Implants INC. Dba Accelus | $190.65 | 2024 | |
| Alphatec Spine, INC | $120.70 | 2024 | Battalion Tlif - PC |
| Nuvasive, INC. | $57.30 | 2019 | |
| Abbvie INC. | $30.28 | 2025 | |
| Supernus Pharmaceuticals, INC. | $21.66 | 2021 | |
| Abbott Laboratories | $15.18 | 2019 | |
| Nevro Corp. | $14.35 | 2021 | |
| Orthofix Medical, INC. | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,564,064.88 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Good listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.